Identifies a novel negative regulatory element and a 53-kDa trans-acting protein responsible for neuron-specific down-regulation of the rat AT1a-R gene.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications for AT1-targeted therapies; leaves open whether this NRE mechanism applies in human disease.
Murasawa et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: